• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人接种 H5N1 疫苗后的急性和持续反应。

Acute and persistent responses after H5N1 vaccination in humans.

机构信息

NIH Center for Human Immunology, NIH, Bethesda, MD 20892, USA.

NIH Center for Human Immunology, NIH, Bethesda, MD 20892, USA; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD, USA.

出版信息

Cell Rep. 2024 Sep 24;43(9):114706. doi: 10.1016/j.celrep.2024.114706. Epub 2024 Sep 4.

DOI:10.1016/j.celrep.2024.114706
PMID:
39235945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11949244/
Abstract

To gain insight into how an adjuvant impacts vaccination responses, we use systems immunology to study human H5N1 influenza vaccination with or without the adjuvant AS03, longitudinally assessing 14 time points including multiple time points within the first day after prime and boost. We develop an unsupervised computational framework to discover high-dimensional response patterns, which uncover adjuvant- and immunogenicity-associated early response dynamics, including some that differ post prime versus boost. With or without adjuvant, some vaccine-induced transcriptional patterns persist to at least 100 days after initial vaccination. Single-cell profiling of surface proteins, transcriptomes, and chromatin accessibility implicates transcription factors in the erythroblast-transformation-specific (ETS) family as shaping these long-lasting signatures, primarily in classical monocytes but also in CD8 naive-like T cells. These cell-type-specific signatures are elevated at baseline in high-antibody responders in an independent vaccination cohort, suggesting that antigen-agnostic baseline immune states can be modulated by vaccine antigens alone to enhance future responses.

摘要

为了深入了解佐剂如何影响疫苗接种反应,我们使用系统免疫学研究了含有或不含有佐剂 AS03 的人类 H5N1 流感疫苗接种,纵向评估了 14 个时间点,包括首次接种和加强接种后第一天的多个时间点。我们开发了一种无监督的计算框架来发现高维反应模式,这些模式揭示了佐剂和免疫原性相关的早期反应动力学,包括一些在加强接种后与加强接种前不同的反应动力学。有或没有佐剂,一些疫苗诱导的转录模式至少在初始接种后 100 天内持续存在。表面蛋白、转录组和染色质可及性的单细胞分析表明,红细胞生成特异性(ETS)家族中的转录因子在塑造这些持久的特征中起作用,主要在经典单核细胞中,但也在 CD8 幼稚样 T 细胞中。在一个独立的疫苗接种队列中,高抗体应答者的基线中这些细胞类型特异性特征升高,这表明抗原不可知的基线免疫状态可以仅通过疫苗抗原来调节,以增强未来的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/18cd32668e93/nihms-2025367-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/2929f90bc4c5/nihms-2025367-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/fc0618cdaa35/nihms-2025367-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/3389c0014124/nihms-2025367-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/18cd32668e93/nihms-2025367-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/2929f90bc4c5/nihms-2025367-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/fc0618cdaa35/nihms-2025367-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/3389c0014124/nihms-2025367-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d13/11949244/18cd32668e93/nihms-2025367-f0005.jpg

相似文献

1
Acute and persistent responses after H5N1 vaccination in humans.人接种 H5N1 疫苗后的急性和持续反应。
Cell Rep. 2024 Sep 24;43(9):114706. doi: 10.1016/j.celrep.2024.114706. Epub 2024 Sep 4.
2
Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.基于细胞的系统生物学分析人用AS03佐剂H5N1禽流感疫苗反应:一项I期随机对照试验
PLoS One. 2017 Jan 18;12(1):e0167488. doi: 10.1371/journal.pone.0167488. eCollection 2017.
3
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.AS03 佐剂甲型 H5N1 流感疫苗加强免疫可改善异源加强免疫后的免疫应答动力学、幅度和持久性:一项双盲随机对照初级研究的开放性非随机扩展。
Vaccine. 2010 Jan 8;28(3):849-57. doi: 10.1016/j.vaccine.2009.10.017. Epub 2009 Oct 14.
4
Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.AS03 佐剂 H5N1 大流行前流感疫苗在 3 至 9 岁儿童中的 II 期、随机、开放、对照研究:接种后 24 个月的安全性和免疫原性持久性随访。
Influenza Other Respir Viruses. 2015 Mar;9(2):68-77. doi: 10.1111/irv.12295. Epub 2015 Feb 5.
5
Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.EB66 细胞培养来源的流感 A/印度尼西亚/5/2005(H5N1) AS03 佐剂疫苗的免疫原性和安全性:一项 1 期随机试验。
J Infect Dis. 2015 Aug 15;212(4):531-41. doi: 10.1093/infdis/jiv091. Epub 2015 Feb 25.
6
Heterologous prime-boost vaccination using an AS03B-adjuvanted influenza A(H5N1) vaccine in infants and children<3 years of age.在3岁以下婴幼儿中使用含AS03B佐剂的甲型H5N1流感疫苗进行异源初免-加强免疫接种。
J Infect Dis. 2014 Dec 1;210(11):1800-10. doi: 10.1093/infdis/jiu359. Epub 2014 Jun 27.
7
An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults.AS03A 佐剂的大流行前 H5N1 疫苗的初免-加强免疫接种方案评估:欧洲成年人的随机研究。
Influenza Other Respir Viruses. 2013 Jan;7(1):55-65. doi: 10.1111/j.1750-2659.2012.00349.x. Epub 2012 Mar 9.
8
Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.储备的大流行前含AS03佐剂的H5N1流感病毒疫苗可在雪貂中对H5N2 2.3.4.4分支病毒攻击提供交叉保护。
Virology. 2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26.
9
H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.含 AS03 的 H5N1 流感疫苗可诱导强烈的交叉反应性和多功能性 CD4 T 细胞应答。
J Clin Immunol. 2011 Jun;31(3):443-54. doi: 10.1007/s10875-010-9490-6. Epub 2010 Dec 21.
10
AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells.AS03 佐剂的 H5N1 禽流感疫苗可调节人外周血单个核细胞中的早期先天免疫特征。
J Infect Dis. 2019 May 5;219(11):1786-1798. doi: 10.1093/infdis/jiy721.

引用本文的文献

1
AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells.AS04通过增强树突状细胞的NOTCH信号传导和记忆B细胞的增殖来驱动卓越的交叉保护性抗体反应。
Front Immunol. 2025 Jul 24;16:1623405. doi: 10.3389/fimmu.2025.1623405. eCollection 2025.
2
Constraints and tunability of antigen-agnostic memory durability.抗原非特异性记忆持久性的限制与可调性。
bioRxiv. 2025 Jul 19:2025.07.18.663399. doi: 10.1101/2025.07.18.663399.
3
Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models.

本文引用的文献

1
Integrating population and single-cell variations in vaccine responses identifies a naturally adjuvanted human immune setpoint.整合疫苗反应中的人群和单细胞变异,确定了一个自然佐剂化的人类免疫基准。
Immunity. 2024 May 14;57(5):1160-1176.e7. doi: 10.1016/j.immuni.2024.04.009. Epub 2024 May 1.
2
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19.流感疫苗接种揭示了先前轻度 COVID-19 的性别二态印迹。
Nature. 2023 Feb;614(7949):752-761. doi: 10.1038/s41586-022-05670-5. Epub 2023 Jan 4.
3
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment.
鼻内流感病毒载体疫苗可在小动物模型中提供针对2.3.4.4b进化枝H5N1感染的保护。
Nat Commun. 2025 Apr 1;16(1):3133. doi: 10.1038/s41467-025-58504-z.
4
Advancing veterinary vaccines design through trained immunity insights.通过训练免疫的见解推进兽医疫苗设计。
Front Vet Sci. 2025 Jan 15;11:1524668. doi: 10.3389/fvets.2024.1524668. eCollection 2024.
5
Predictive signatures of immune response to vaccination and implications of the immune setpoint remodeling.疫苗接种免疫反应的预测特征及免疫设定点重塑的影响。
mSphere. 2025 Feb 25;10(2):e0050224. doi: 10.1128/msphere.00502-24. Epub 2025 Jan 24.
6
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans.人类对多种疫苗抗体反应持久性的预测因素和机制的系统疫苗学分析。
Nat Immunol. 2025 Jan;26(1):116-130. doi: 10.1038/s41590-024-02036-z. Epub 2025 Jan 2.
ETV3 和 ETV6 通过抑制巨噬细胞命运决定来促进单核细胞向树突状细胞分化。
Nat Immunol. 2023 Jan;24(1):84-95. doi: 10.1038/s41590-022-01374-0. Epub 2022 Dec 21.
4
Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.泛疫苗分析揭示了预测疫苗接种后抗体反应的固有免疫内型。
Nat Immunol. 2022 Dec;23(12):1777-1787. doi: 10.1038/s41590-022-01329-5. Epub 2022 Oct 31.
5
Normalizing and denoising protein expression data from droplet-based single cell profiling.基于液滴的单细胞分析的蛋白质表达数据的标准化和去噪。
Nat Commun. 2022 Apr 19;13(1):2099. doi: 10.1038/s41467-022-29356-8.
6
Transcriptional correlates of malaria in RTS,S/AS01-vaccinated African children: a matched case-control study.RTS,S/AS01 疫苗接种的非洲儿童疟疾转录相关因素:一项匹配病例对照研究。
Elife. 2022 Jan 21;11:e70393. doi: 10.7554/eLife.70393.
7
Single-cell transcriptomic profiles reveal changes associated with BCG-induced trained immunity and protective effects in circulating monocytes.单细胞转录组谱揭示了与 BCG 诱导的训练免疫和循环单核细胞保护作用相关的变化。
Cell Rep. 2021 Nov 16;37(7):110028. doi: 10.1016/j.celrep.2021.110028.
8
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.免疫接种流感疫苗的单细胞表观基因组学和转录组学特征。
Cell. 2021 Jul 22;184(15):3915-3935.e21. doi: 10.1016/j.cell.2021.05.039. Epub 2021 Jun 25.
9
Emerging concepts in the science of vaccine adjuvants.疫苗佐剂科学中的新观点。
Nat Rev Drug Discov. 2021 Jun;20(6):454-475. doi: 10.1038/s41573-021-00163-y. Epub 2021 Apr 6.
10
Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature.佐剂乙型肝炎疫苗的转录谱显示出个体间的变异性和同质性,但具有共享的核心特征。
Sci Transl Med. 2020 Nov 11;12(569). doi: 10.1126/scitranslmed.aay8618.